Share this:
March 2022
carcinoid.org about us for patients for doctors resources events news
Ask the NET Expert, March 2022
Featuring Jaydira Del Rivero, MD
Ask the NET Expert, CCF’s new website-based program, continues with Jaydira Del Rivero, MD, the featured expert answering questions from the neuroendocrine tumor community during March 2022. A medical oncologist and endocrinologist, Dr. Del Rivero is the Director of the Neuroendocrine Tumor Program as well as a research scientist in the Developmental Therapeutics Branch at the National Cancer Institute of the National Institutes of Health in Maryland. 
Dr. Jaydira Del Rivero - Ask the Experts
Launched last month, the Ask the NET Expert program gives NET patients and loved ones, as well as people seeking a diagnosis, the unique opportunity to get the expertise of doctors from around the country in all areas of medicine including medical oncology, surgical oncology, endocrinology, radiology, nuclear medicine, gastroenterology, and more via CCF’s website. Each month a different NET expert will answer your questions.

Non-case-specific questions can be submitted via the Submit Your Question form located here, AskTheNETExpertSubmitYourQuestion.

Questions should be general in nature as the physicians cannot answer case-specific questions. Questions can be on any NET-related subject including, but not limited to, diagnosis, biomarkers, pathology reports, clinical trials, and treatments.

We hope to be able to answer every question received but this may not be possible.

We post the questions and responses on our website, but please know your name will not be published.

Dr. Del Rivero is the Principal Investigator of the Natural History Study for Neuroendocrine Neoplasm and Adrenocortical Cancer to provide the basis of further development of therapeutic interventions, prevention/screening guidelines, endpoints for future clinical trials, and patient-reported outcome measures. Dr. Del Rivero’s current research is focused on the development of novel treatment approaches and targeted therapies for endocrine malignancies such as advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs), adrenocortical cancer and pheochromocytoma/paraganglioma.

Dr. Del Rivero serves on the Board of Directors of the North American Neuroendocrine Tumor Society (NANETS) and currently serves as co-chair on the Guidelines Committee.

Dr. Del Rivero is currently involved in the following clinical trials:

Click here to see the February Ask the NET Expert Questions and Answers: 
Each month we will share all previous Questions and Answers here: www.carcinoid.org/ask-the-net-expert/
The Carcinoid Cancer Foundation's educational, awareness and advocacy activities are made possible by your contributions. These crucial activities lead toward early detection, improving the quality of life for cancer survivors, and ultimately to a cure. The Carcinoid Cancer Foundation is a 501(c)(3) nonprofit organization. All contributions to the Carcinoid Cancer Foundation are tax-deductible to the extent allowed by law. Thank you for your support. 
Carcinoid Cancer Foundation
118 North Bedford Road, Suite 100
Mt. Kisco, NY 10549
Phone: 888.722.3132
Email: carcinoid@carcinoid.org 
facebook twitter You tube Blog
118 N. Bedford Road Suite 100 | Mt. Kisco, NY 10549-2555 US
powered by emma
Subscribe to our email list.